## CCI: Crown Castle Inc. - XLRE: Real Estate

### Executive Summary

VALUE thesis: PEG 1.37 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($85.35)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Lazard Asset Management LLC Has $562.22 Million Stake in Crown Castle Inc. $CCI**
- Source: MarketBeat | 20251214T134151 | Neutral | Relevance: 100%
- Lazard Asset Management LLC significantly increased its stake in Crown Castle Inc. (NYSE:CCI) during Q2, now owning 5,472,810 shares valued at $562.22 million. Crown Castle reported strong Q3 earnings, beating analyst expectations, and declared a quarterly dividend of $1.0625 per share, representing a 4.7% yield. Despite a "Moderate Buy" average analyst rating, the company faces negative profitability metrics and trades with a negative P/E ratio.

**2. Thrivent Financial for Lutherans Has $113.83 Million Holdings in Crown Castle Inc. $CCI**
- Source: MarketBeat | 20251214T132351 | Neutral | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Crown Castle Inc. (NYSE:CCI), acquiring an additional 115,330 shares to bring its total holdings to over 1.1 million shares valued at $113.83 million. Other institutional investors have also adjusted their positions in the real estate investment trust, which has an average analyst rating of "Moderate Buy" and an average price target of $111.59. Crown Castle recently announced a quarterly dividend of $1.0625 per share.

**3. Benchstone Capital Management LP Makes New Investment in Crown Castle Inc. $CCI**
- Source: MarketBeat | 20251213T095028 | Neutral | Relevance: 100%
- Benchstone Capital Management LP has purchased a new stake in Crown Castle Inc. (NYSE:CCI) worth approximately $14.5 million during the second quarter. Other institutional investors like Wilmington Savings Fund Society FSB and Creative Financial Designs Inc. ADV also adjusted their holdings in the real estate investment trust. Analyst ratings for Crown Castle vary, with a current average of "Moderate Buy" and a price target of $111.59.

**4. Global Egg Freezing and Embryo Banking Market Analysis,**
- Source: GlobeNewswire | 20251216T020943 | Bullish | Relevance: 100%
- The global Egg Freezing and Embryo Banking Market is projected to grow from USD 4.49 billion in 2024 to USD 11.26 billion by 2030, driven by societal shifts toward delayed parenthood and advancements in cryopreservation. Despite high costs posing a significant challenge, the integration of AI in embryo selection is enhancing success rates and boosting market expansion. Key players include ReproTech, Cryo-Cell, and CCRM Fertility Clinic.

**5. Crown Castle Inc. $CCI Shares Acquired by Engineers Gate Manager LP**
- Source: MarketBeat | 20251213T104922 | Neutral | Relevance: 100%
- Engineers Gate Manager LP significantly increased its stake in Crown Castle Inc. by 15,775.2%, acquiring an additional 387,597 shares to own a total of 390,054 shares valued at approximately $40.07 million. Despite beating quarterly EPS, Crown Castle reported negative net margin and ROE, and its FY2025 EPS guidance is below analyst forecasts. The company declared a quarterly dividend of $1.0625, while institutional ownership stands at nearly 90.77%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Barclays | $101 | $104 | -3% |
| 2025-11-17 | Barclays | $104 | $120 | -13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Barclays | down | Equal-Weight |
| 2025-11-17 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($3.04M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.9% (+0.1%)
- Blackrock Inc.: 10.5% (+0.5%)
- Cohen & Steers Inc.: 8.2% (+18.2%)
- State Street Corpora: 5.0% (+1.2%)
- Wellington Managemen: 3.1% (-28.4%)

### Key Risks

1. Insider selling cluster: $3.0M in recent transactions.
2. Long-term trend broken: trading 9.5% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +3.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Forward P/E 26.1x attractive for 42% earnings growth. Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($3.0M in 90 days), potential headwind. Institutional flow bearish (3 selling vs 7 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $39.0B |
| Beta | 0.96 |
| 52W Range | $84.20 - $115.76 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 26.1 |
| Current P/E | 37.0 |
| YoY Growth | 41.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -2.3% to 0.8% (+3.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.2pp (needs >4.0% for momentum thesis). MRS_5 at 1.2% confirms short-term momentum alignment. Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 45. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.78% (CS: 41) | Neutral |
| RSI_14 | 44.8 | Neutral |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 0.994x | Below |
| vs SMA50 | 0.966x | Below |
| vs SMA200 | 0.905x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $89.49
- **Stop Loss:** $85.35 (4.6% risk)
- **Target:** $97.77 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 241
- **Position Value:** $21,567.09
- **Portfolio %:** 21.57%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $0.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.64 | +30.6% |
| 2025Q2 | $0.51 | $0.61 | +19.6% |
| 2025Q1 | $-0.05 | $0.65 | +1485.3% |
| 2024Q4 | $0.42 | $0.73 | +74.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*